Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 General health perception, treatment satisfaction, and fatigue

From: Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

Characteristics

Range

General health perception

 

T1 - best

≥6

T2 - intermediate

5

T3 - worst

≤4

Mean ± SD

4.6 ± 1.3

TSQM scores

 Total

T1 - best

≥81

T2 - intermediate

68–80

T3 - worst

≤67

Mean ± SD

74 ± 16

Effectiveness

T1 - best

≥76

T2 - intermediate

61–75

T3 - worst

≤60

Mean ± SD

71 ± 21

Side effects

T1 - best

100

T2 - intermediate

70–99

T3 - worst

≤69

Mean ± SD

81 ± 26

Convenience

T1 - best

≥81

T2 - intermediate

66–80

T3 - worst

≤65

Mean ± SD

70 ± 17

Global

T1 - best

≥86

T2 - intermediate

71–85

T3 - worst

≤70

Mean ± SD

78 ± 19

PROMIS fatigue T-scores

 

T1 - best

 ≤53

T2 - intermediate

54–60

T3 - worst

 ≥61

Mean ± SD

57 ± 9

  1. Respondents were ranked by their scores and divided into tertiles (T1, T2 and T3) corresponding to best, intermediate, and worst, respectively. GHP was measured on a 1–7 scale (1 = poor health and 7 = excellent health). TSQM transformed scores were measured on a 0–100 scale (0 = worst satisfaction and 100 = perfect satisfaction). Fatigue was assessed using the PROMIS Fatigue Short Form 7a and Parent/Caregiver Proxy respectively ( 29.4 = least fatigue and 83.2 = most fatigue)
  2. GHP General health perception, PROMIS Patient-Reported Outcome Management Information System, SD standard deviation, SCIG subcutaneous immunoglobulin, TSQM Treatment Satisfaction Questionnaire for Medication